Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the gross margin high or low?
The gross margin of 88.34% is 765% above its 5-year average of 10.22%, near the high end of its 5-year range (0.00%–100.00%).
67.63% above its 12-month average of 52.70%.
Reported quarterly gross margin; no daily interpolation. Q2 FY2026 (2026-06-30): 86.88%.
GROSS MARGIN
88.34%
GROSS MARGIN AVG TTM
52.70%
GROSS MARGIN AVG 3Y
0.00%
GROSS MARGIN AVG 5Y
10.22%
GROSS MARGIN AVG 10Y
N/A
GROSS MARGIN AVG 15Y
N/A
GROSS MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
+67.63%
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
+764.52%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
41.38%
median of 853 covered companies
CURRENT VS SECTOR MEDIAN
+113.48%
vs the sector median at left
Jupiter Neurosciences, Inc.
Market Cap
$1.43M
Gross Margin
88.34%
TTM Avg
52.70%
3Y Avg
0.00%
5Y Avg
10.22%
Market Cap
$1.43M
Gross Margin
33.34%
TTM Avg
40.48%
3Y Avg
28.36%
5Y Avg
50.23%
Market Cap
$1.47M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$1.47M
Gross Margin
10.31%
TTM Avg
42.76%
3Y Avg
35.97%
5Y Avg
38.88%
Market Cap
$1.36M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
| NAME | MARKET CAP | GROSS MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Jupiter Neurosciences, Inc. (JUNS) | $1.43M | 88.34% | 52.70% | 0.00% | 10.22% |
| INVO Fertility, Inc. (IVF)vs › | $1.43M | 33.34% | 40.48% | 28.36% | 50.23% |
| Curis, Inc. (CRIS)vs › | $1.42M | 99.28% | 99.31% | 98.49% | 97.34% |
| NEXGEL, Inc. (NXGL)vs › | $1.44M | 35.07% | 35.55% | 23.19% | 8.35% |
| Lakewood-Amedex Biotherapeutics, Inc. (LABT)vs › | $1.47M | 0.00% | 0.00% | 0.00% | 0.00% |
| PMGC Holdings Inc. (ELAB)vs › | $1.47M | 10.31% | 42.76% | 35.97% | 38.88% |
| Artelo Biosciences, Inc. (ARTL)vs › | $1.36M | 0.00% | 0.00% | 0.00% | 0.00% |
| Genprex, Inc. (GNPX)vs › | $1.35M | 0.00% | 0.00% | 0.00% | 0.00% |
| NewcelX Ltd. (NCEL)vs › | $1.32M | 0.00% | 0.00% | 0.00% | 0.00% |
| Silo Pharma, Inc. (SILO)vs › | $1.60M | -1128.89% | -518.50% | -213.30% | -126.70% |
Gross Margin
88.3%
(Revenue - COGS) / Revenue
Gross Margin = Gross Profit / Revenue
Gross margin is the percentage of revenue remaining after the cost of goods sold, reflecting core product profitability.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | GROSS MARGIN |
|---|---|
| 2026-06-30 | 86.88% |
| 2026-03-31 | 76.61% |
| 2025-12-31 | 100.00% |
| 2025-09-30 | 0.00% |
| 2025-06-30 | 0.00% |
| 2025-03-31 | 0.00% |
| 2024-12-31 | 0.00% |
| 2024-09-30 | 0.00% |
| 2024-06-30 | 0.00% |
| 2024-03-31 | 0.00% |
| 2023-12-31 | 0.00% |
| 2023-09-30 | 0.00% |
| 2023-06-30 | 0.00% |
| 2023-03-31 | 0.00% |
| 2022-06-30 | 100.00% |
| 2022-03-31 | 0.00% |
| 2021-12-31 | 0.00% |
| 2021-09-30 | 0.00% |
| 2021-06-30 | 100.00% |
| 2021-03-31 | 100.00% |
| 2020-12-31 | 100.00% |
| 2020-09-30 | 0.00% |
